Mutation
The putative cancer-causing PDGs driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.
| Showing page 183 |
first page | previous page | next page | last page |
| HGNC Symbol | Ensembl Gene ID | Overall_Mscore | No. of Cancer Types |
| MCL1 | ENSG00000143384 | 0.00 | 0 |
| CYB5R1 | ENSG00000159348 | 0.00 | 0 |
| KMO | ENSG00000117009 | 0.00 | 0 |
| SLC25A22 | ENSG00000177542 | 0.00 | 0 |
| UQCC3 | ENSG00000204922 | 0.00 | 0 |
| ABCD2 | ENSG00000173208 | 0.00 | 0 |
| SLC27A2 | ENSG00000140284 | 0.00 | 0 |
| CHSY1 | ENSG00000131873 | 0.00 | 0 |
| TAOK2 | ENSG00000149930 | 0.00 | 0 |
| CNGB1 | ENSG00000070729 | 0.00 | 0 |
| CHST5 | ENSG00000135702 | 0.00 | 0 |
| SLC25A39 | ENSG00000013306 | 0.00 | 0 |
| CYP4F3 | ENSG00000186529 | 0.00 | 0 |
| CYP4F11 | ENSG00000171903 | 0.00 | 0 |
| BAX | ENSG00000087088 | 0.00 | 0 |
| BRSK1 | ENSG00000160469 | 0.00 | 0 |
| ASPRV1 | ENSG00000244617 | 0.00 | 0 |
| SLC25A18 | ENSG00000182902 | 0.00 | 0 |
| SLC25A17 | ENSG00000100372 | 0.00 | 0 |
| SREBF2 | ENSG00000198911 | 0.00 | 0 |
|
Showing page 183 |
first page | previous page | next page | last page |